Top-News
Biotechnologie Kanada

Braxia Scientific Corp. Aktie

Aktie
WKN:  A3CPBM ISIN:  CA1057361026 US-Symbol:  BRAXF
0,0026 €
-0,0004 €
-14,29%
0,0027 $ 06.12.24
Handeln Depot/Watchlist
Aktienanzahl *
263,71 Mio.
Marktkapitalisierung *
928,49 Tsd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 15.01.2024

Braxia Scientific Corp. News

29.11.22 - PR Newswire
Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America
Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America PR Newswire
01.11.22 - PR Newswire
Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders
Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders PR Newswire
04.10.22 - PR Newswire
KetaMD Expands Access to Breakthrough Ketamine Therapy in Florida to Battle the Growing Mental Health Crisis and Shortage of Mental Health Care Providers
KetaMD Expands Access to Breakthrough Ketamine Therapy in Florida to Battle the Growing Mental Health Crisis and Shortage of Mental Health Care Providers PR Newswire
21.09.22 - PR Newswire
Braxia Scientific Announces Board Appointment
Braxia Scientific Announces Board Appointment PR Newswire
16.09.22 - PR Newswire
Braxia Scientific Announces Court Approval of Class Action Settlement in Canada
Braxia Scientific Announces Court Approval of Class Action Settlement in Canada PR Newswire
12.09.22 - PR Newswire
Braxia Scientific Launches KetaMD in Florida; First Patients Complete Initial Virtual Ketamine Treatments At-Home
Braxia Scientific Launches KetaMD in Florida; First Patients Complete Initial Virtual Ketamine Treatments At-Home PR Newswire
09.09.22 - PR Newswire
Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022
Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 PR Newswire
29.08.22 - PR Newswire
Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U.S. Increasing Treatment Access for Mental Health Patients
Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U.S. Increasing Treatment Access for Mental Health Patients PR Newswire
03.08.22 - PR Newswire
Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.
Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the ...
29.07.22 - PR Newswire
Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results
Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results PR Newswire
27.07.22 - PR Newswire
Braxia Scientific Bolsters Leadership with Strategic Hires; Adds Chief Information Officer and Global Pharmaceutical Industry Leader as VP R&D and Growth
Braxia Scientific Bolsters Leadership with Strategic Hires; Adds Chief Information Officer and Global Pharmaceutical Industry Leader as VP R&D and Growth PR Newswire
24.06.22 - PR Newswire
Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond
Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond PR Newswire
15.06.22 - PR Newswire
Braxia Scientific Expands Clinic Footprint in Canada Providing Greater Access to Network of Specialists Delivering Ketamine and Psilocybin Treatments for Depression and Related Mental Health Disorders
Braxia Scientific Expands Clinic Footprint in Canada Providing Greater Access to Network of Specialists Delivering Ketamine and Psilocybin Treatments for Depression and Related ...
02.06.22 - PR Newswire
Braxia Scientific Presents Positive Preliminary Findings from Phase II Randomized, Multi-Dose Clinical Trial of Psilocybin-Assisted Therapy for Treatment Resistant Depression
Braxia Scientific Presents Positive Preliminary Findings from Phase II Randomized, Multi-​Dose Clinical Trial of Psilocybin-​Assisted Therapy for Treatment Resistant Depression PR ...
20.05.22 - PR Newswire
Braxia Scientific Receives Health Canada Special Access Program Approval to Provide Psilocybin-Assisted Therapy for Depression in Ontario
Braxia Scientific Receives Health Canada Special Access Program Approval to Provide Psilocybin-​Assisted Therapy for Depression in Ontario PR Newswire
19.05.22 - PR Newswire
Braxia Scientific to Present at H.C. Wainwright Global Investment Conference, Miami from May 24-26, 2022
Braxia Scientific to Present at H.C. Wainwright Global Investment Conference, Miami from May 24-26, 2022 PR Newswire
18.05.22 - PR Newswire
Braxia Scientific CEO to Speak at American Psychiatric Association Annual Meeting on Treatment Resistant Depression and Ketamine Guidelines Published in American Journal of Psychiatry
Braxia Scientific CEO to Speak at American Psychiatric Association Annual Meeting on Treatment Resistant Depression and Ketamine Guidelines Published in American Journal of ...
13.04.22 - PR Newswire
UPDATE - Braxia Scientific Reaches Agreements to Settle Class Actions in US and Canada
UPDATE - Braxia Scientific Reaches Agreements to Settle Class Actions in US and Canada PR Newswire
13.04.22 - PR Newswire
Braxia Scientific Reaches Agreements to Settle Class Actions in US and Canada
Braxia Scientific Reaches Agreements to Settle Class Actions in US and Canada PR Newswire
01.04.22 - PR Newswire
Braxia Scientific CEO and CMO, Invited to Speak as Experts at the Ketamine and Related Compounds 2022 International Conference hosted by University of Oxford April 4-6
Braxia Scientific CEO and CMO, Invited to Speak as Experts at the Ketamine and Related Compounds 2022 International Conference hosted by University of Oxford April 4-6 PR ...

Newssuche

Videos

newspaper
05.12.24 -2,79%
Technical Trading: Gold Long bis...
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 7 Laufzeit: OpenEnd Einstieg: Market ... Mehr »